Effect of Weight Loss Medications on Hepatic Steatosis and Steatohepatitis: A Systematic Review

Non-alcoholic fatty liver disease (NAFLD) is a common comorbidity in individuals with obesity. Although multiple pharmacotherapeutics are in development, currently there are limited strategies specifically targeting NAFLD. This systematic review summarizes the existing literature on hepatic effects...

Descripción completa

Detalles Bibliográficos
Autores principales: Pan, Chelsea S., Stanley, Takara L.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2020
Materias:
Endocrinology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7046622/
https://www.ncbi.nlm.nih.gov/pubmed/32153507
http://dx.doi.org/10.3389/fendo.2020.00070

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7046622/
https://www.ncbi.nlm.nih.gov/pubmed/32153507
http://dx.doi.org/10.3389/fendo.2020.00070

Ejemplares similares